We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600160:SSEZhejiang Juhua Co., Ltd. Class A Analysis

Data as of 2026-06-13 - not real-time

CN¥42.39

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Zhejiang Juhua is trading at CNY 42.39, well above its DCF‑derived fair value of roughly CNY 25.9, suggesting the market may be pricing in optimistic expectations. The stock sits above its 20‑day, 50‑day and 200‑day moving averages (≈CNY 36.6, 35.6 and 36.5), a classic bullish signal, while the MACD line remains positive and the histogram is expanding, confirming recent momentum. However, the RSI of 68 hints at an overbought condition that could precede a short‑term pullback. Valuation metrics are elevated, with a trailing P/E of 27.7 and a forward P/E near 18, implying the price is premium to earnings growth. The company delivers solid profitability (operating margin ≈26%, net margin ≈15%) and a healthy ROE of 21%, but free cash flow is negative, raising questions about cash generation sustainability. Dividend sustainability looks robust, as the payout ratio is only 27% and the dividend yield stands at 1.32%. Volatility is high at 59% over the past 30 days, yet the beta is extremely low (≈0.06), indicating limited systematic market risk, while trading volume is rising, supporting liquidity.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Price above key moving averages indicating bullish trend
  • RSI in overbought territory suggesting near‑term downside risk
  • High short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong operating margins and ROE supporting earnings stability
  • Elevated P/E relative to peers implying limited upside
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Cautious
Model confidence: 5/10

Key Factors

  • Market price significantly above DCF fair value
  • Modest revenue growth (≈3.7%) limiting future earnings expansion
  • Negative free cash flow indicating cash generation concerns

Key Metrics & Analysis

Financial Health

Revenue Growth3.70%
Profit Margin15.26%
P/E Ratio27.7
ROE21.05%
ROA10.49%
Debt/Equity30.61
P/B Ratio5.3
Op. Cash FlowCN¥6.7B
Free Cash FlowCN¥-1036169792

Technical Analysis

TrendNeutral
RSI68.1
SupportCN¥31.62
ResistanceCN¥43.05
MA 20CN¥36.62
MA 50CN¥35.63
MA 200CN¥36.48
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Fair ValueCN¥25.91
GradeOvervalued
TypeValue
Dividend Yield1.32%

Risk Assessment

Beta0.06
Volatility59.13%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.